Pamidronate disodium salt

CAS No. 57248-88-1

Pamidronate disodium salt( APD | CGP 23339A | Pamidronic Acid )

Catalog No. M15087 CAS No. 57248-88-1

Pamidronate disodium, a bisphosphonate drug,  can help to strengthen bones.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 36 In Stock
10MG 49 In Stock
25MG 78 In Stock
50MG 128 In Stock
100MG 184 In Stock
200MG 276 In Stock
500MG 476 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Pamidronate disodium salt
  • Note
    Research use only, not for human use.
  • Brief Description
    Pamidronate disodium, a bisphosphonate drug,  can help to strengthen bones.
  • Description
    Pamidronate disodium, a bisphosphonate drug,  can help to strengthen bones.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    APD | CGP 23339A | Pamidronic Acid
  • Pathway
    Microbiology/Virology
  • Target
    HBV
  • Recptor
    HAP| FPPS
  • Research Area
    Metabolic Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    57248-88-1
  • Formula Weight
    279.03
  • Molecular Formula
    C3H9NNa2O7P2
  • Purity
    >98% (HPLC)
  • Solubility
    Water: 56 mg/mL (200.69 mM)
  • SMILES
    OC(OP([O-])=O)(OP([O-])=O)CCN.[H]O[H].[H]O[H].[H]O[H].[H]O[H].[H]O[H].[H]O[H].[H]O[H].[Na+].[Na+]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Bergstrom JD, et al. Arch Biochem Biophys. 2000 Jan 1;373(1):231-4
molnova catalog
related products
  • AB-423

    AB-423 is a novel potent, class II HBV capsid inhibitor that shows potent inhibition of HBV replication with EC50 of 0.08-0.27 uM, with no significant cytotoxicity (CC50>10 uM).

  • Canocapavir

    Canocapavir (ZM-H1505R) is a novel orally available HBV coat protein modulator with antiviral activity that induces conformational changes in the linker region of the HBV core protein, and can be used for the treatment of hepatitis B virus.

  • GLP-26

    GLP-26 is a novel potent HBV capsid modulator that reduces secreted HBeAg in HepNTCPDL cells transfected with HBV wild type with EC50 of 0.7 uM.